Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2012-05-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta16230 |